Celiac Disease Eligible for CMDRP Research Funding for the First Time – Marilyn’s Message January 2023
2023 promises to be a year full of robust research, advocacy, and education efforts on behalf of our patient community.
Continue Reading2023 promises to be a year full of robust research, advocacy, and education efforts on behalf of our patient community.
Continue ReadingThe American College of Gastroenterology has updated its guidelines for the diagnosis and management of celiac disease, bringing current the recommendations outlined in 2013.
Continue ReadingCraig Pinto has brought inspiring creativity, charisma, generosity, and heart to his role as the Celiac Disease Foundation’s New York Area Development Officer.
Continue ReadingOn behalf of the entire celiac disease patient community, thank you for your tremendous support of our Gift of Hope campaign. We are so grateful to everyone who contributed as together we raised funds to support research, advocacy, and education.
Continue ReadingConsider joining the CeDar Rose Study, a remote celiac disease study that will monitor individual gluten tolerance.
Continue ReadingCDF is pleased to announce the release of a report representing the culmination of two years of collaboration with Los Angeles County and other partners to address chronic, growing food insecurity among dietary-restricted patients.
Continue ReadingWe are pleased to share this overview of our work in 2022, and we thank our individual donors and corporate partners for their ongoing generosity that makes this work possible.
Continue ReadingCeliac Disease Foundation honors retiring Board Member Jim Watson for his dedicated service.
Continue ReadingCeliac Disease Foundation honors retiring Board Member Rhonda Resnick for her dedicated service.
Continue ReadingWith more than 200 symptoms, celiac disease can be difficult to diagnose. If you have unexplained symptoms or have a family member with celiac disease, complete the Symptoms Assessment Tool made possible by the generous support of Proud Sponsor Schär.
Continue Reading